Presentation Open Access
{ "inLanguage": { "alternateName": "eng", "@type": "Language", "name": "English" }, "description": "<p>This is <a href=\"https://med.uottawa.ca/epidemiology/people/krentel-alison\">Alison Krentel</a>’s presentation at the monthly [virtual] Antiviral Drug Discovery (AViDD) Open Science Forum on 2023-03-15. Her talk centers on some of the challenges to equity and effectiveness faced in the rollout and use of medical products, and the opportunities to consider the end user during development stage. </p>\n\n<p>You can find a recording of their talk on the <a href=\"https://www.youtube.com/channel/UCDwwIkoBVkqzVYn0t5AWmeQ/featured\">AViDD Open Science Forum Youtube page</a>.</p>", "license": "https://creativecommons.org/licenses/by/4.0/legalcode", "creator": [ { "affiliation": "University of Ottawa", "@id": "https://orcid.org/0000-0001-7213-1577", "@type": "Person", "name": "Krentel, Alison" } ], "url": "https://zenodo.org/record/7781958", "datePublished": "2023-03-15", "keywords": [ "AViDD", "Antiviral Drug Discovery", "Antiviral Drug Discovery Open Science Forum", "AViDD Open Science Forum", "Open Science Forum", "open science" ], "@context": "https://schema.org/", "identifier": "https://doi.org/10.5281/zenodo.7781958", "@id": "https://doi.org/10.5281/zenodo.7781958", "@type": "PresentationDigitalDocument", "name": "Now it's been made, how will it be used? Exploring the pathway from lab to community" }
All versions | This version | |
---|---|---|
Views | 22 | 22 |
Downloads | 15 | 15 |
Data volume | 39.2 MB | 39.2 MB |
Unique views | 21 | 21 |
Unique downloads | 14 | 14 |